en

PRODUCT DETAIL

Vixargio 20 mg filmom obalené tablety

Code 2269E
MA number 16/0267/22-S
Product Form: tbl flm 28x1x20 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 27.10.2022
Validity: 27.10.2027
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Vixargio 20 mg_01.2023.pdf  
PIL: PIL_Vixargio 15 mg_20 mg_01.2023.pdf  
Safety feature Yes
Data update: 26.01.2023
eu-flag.png sk-flag.png